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The complete amino acid sequence of the Laburnum ulpinum di-N-acetylchitobiose-binding lectin was determined by using a protein sequencer after 
digestion with endoproteinases Lys-C and Asp-N, and compared with those of other leguminous plant lectins. 
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1. INTRODUCTION 
The anti-H(O) hemagglutinating activity in extracts 
from the seeds of Eaburnum alpinum was first 
discovered by Renkonen [lj and further confirmed by 
Morgan and Watkins [2,3]. The hemagglutination- 
inhibition studies on crude extracts from the seeds 
revealed a specificity towards di-iV-acetylchitobiosyl 
residues [3-51, and human A, H and neuraminidase- 
treated human Lea blood-group substances were also 
good inhibitors of the Laburnum lectin [5]. In a 
previous paper [6] we have shown the specific purifica- 
tion and characterization of two kinds of Laburnum 
alpinum lectin, a Cytisus-type di-N-acetylchitobiose- 
binding lectin (LAA-I) and a new type lectin which is in- 
hibited by laclose or galactose (LAA-II). We have also 
determined the primary structures of the Lotus tetra- 
gonolobus anti-H(O) lectin (LTA) [7] and two types of 
the Ulex europews anti-H(O) lectins (UEA-I and II) 
[g], and compared them with those of several lectins. 
Exte;lsive homologies were found among them. In this 
study, we determined the complete amino-acid se- 
quence of the anti-H(O) Laburnum alpinum lectin I 
(LAA-I) by using a protein sequencer. After digestion 
of the lectin with two kinds of endoproteinases, Lys-C 
and Asp-N, the resulting peptides were purified by 
reversed-phase high-performance liquid chroma- 
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Abbreviations: Con A, concanavalin A; HPLC, high-pcrformnnce 
liquid chromatography; LCL, tens cu/inari.s (lentil) Icctin; LTA, 
to/l,s tetrugorrolobus Icctin; PHA, Pl~asco/uv vulgar/s Iectin; SBA, 
Glyci~rc 1)1(1x lectin; SL, Onobrychis vicifuliu (sainfoin) Icctin; UEA, 
U1ti.y europeus lectin; DBA, Dolictros biflorus lectin; LOL, Lorlrytws 
orhts Icctin; Lt31., Pliuseolrts li!rrertsis Icctin; ECorL, 4,vlrrim1 rur- 
al/odendvo~r Irctin; TFA, trifluoroacetic acid 
tography (HPLC) and subjected to the sequence ana- 
lysis. The complete primary structure of this lectin was 
compared with those of 14 lectins already determined, 
including those of LTA [7] and UEA-I and II [g]. 
Among these lectins, extensive homologies, especially 
between LAA-I and UEA-II, were found. 
2. MATERIALS AND METHODS 
The seeds of Luburnum alpinum were obtained from F.W. 
Schumacher Co., Sandwich, MA. C4 and Cllrp Bondaspheres (100 A, 
for reversed-phase chromatography were obtained from Waters 
(Eurlington, MA). Endoproteinases Lys-C (Lysob,~etcren~yy,no2e:iess) 
and Asp-N (Pseudomonus frugi) were purchased from Boehringer 
(Mannheim, Germany). 
The Laburnum alpinum lectin I was isolated and purified according 
to th’e methods reported previousiy 161. This affinity-purified lectin 
was further purified by reversed-phase HPLC on a column of Cq us- 
ing a linear gradient (O-100%) of 2-propanol/acetonitrile (7:3) in 
distilled water containing 0. I Vo trifluoroacetic acid (TFA) in 60 min 
at a flow rate of 1 ml/min. Then the Itc&h thus purified (0.5 mg in 
150 pl of 50 mM phosphate buffer, pH 8.0) was digested with 4 *g of 
Lys-C or with 2 #cg of Asp-N for 18 h at 39°C. The peptide fragments 
obtained were separated by reversed-phase HPLC on a column of Cls 
using a linear gradient (O-60%) of 2.propanol/acctonitrile (7: 3) in 
distilled water containing 0.1% TFA in 60 min at a flow rate of 
I ml/min. Elution profiles were monitored at 220 nm. The peptide 
fragments were collected manually. 
Sequence analyses of the intact proteins and of the purified peptides 
were performed on a 6600 ProSequencer solid-phase protein se- 
quencer (MilliGenBiosearch, Burlington, MA, USA) and a PSQ-I 
gas-phase protein sequencer (Shimadzu, Kyoto, Japan). 
Hydropathy plots were generated by the method of Kyte and 
Doolittle [9] and secondary structure predictions were carried out by 
using the DNA Strider (Centre d’Etudes Nucleaires de Saclay, Gif- 
sur-Yvette Cedex, France). 
3. RESULTS 
3.1. Determination of’ the primary structure 
Purification and sequencing of the peptides, obtained 
after digestion of LAA-I with endoproteinases Lys-C, 
Fig. 1 and ASP-N, Fig, 2 provided enough overlapping 
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-c rregeents 
Glu-.Pro-pro-IIo-6In-s@r-Ar~-LYn 
Phe-Vsl-Pro-ken-~ln-Aan 
x G1U-Pr0-Pro-Ile-C1~-Se~-dr~-LyO 
Wls-lle-Cly-Vsl-Aep-v~l-A~n-~~r-lle-Lya 
Leu-Asn-Clu-Leu-Ser-PRe_Aen_Phe_Ae9-Lyn 
WiS-IIE-Oly-Vnl-Amp-Vol-Asn-SeP-llc-Lyn 
Ala-Tyr-Am-Pro-Trp-Asp-Pke-Lya 
Leu-Am-Glu-Lcu-Se?Phe-Ann-Phe-Asp-Lln 
= TrQ-A6P-trp-Ar~-A~n-Gly-AID_A6n- 
-Val-Vel-JJe-ThP-TyP-Arg-Ala-Pro-Thr-lays 
Tfrp-Aep-Tpp-APT-Asn-Gly-Aap-Vel-Ala-A%n- 
-VnI-Vnl-lie-Thr-Tyr-Arg-Alo-Pro-IRr-Lyo 
* Lcu-Ann-Clu-Leu-,ScP-Phe-Asn-Pke-Aep-Lye 
‘a Vel-Ale-See-Phe-Ala-Thr-Scr-Phe-Ser-PhC- 
-V.9l-“lll-L”Fl 
Scr-Val-ajy-Phe-Sfr-Ale-Cly-Val-Gly-Aen- 
-Ale-Ala-Lys 
Phe-Val-Prc,-Aen-Cln-Asn-Aan-lle-Lcu-Bhe-LeU-Phe- 
-Gin-Gly-Val-Aln-Scr-V~l-Ser-ThP-Tar-Gly- 
-Ynl-I.CII- .__ _-- 
8 PLe-Val-Ppo-Aen-Cln-Asn-Atin-llc-Leu-PRe- 
-Glli-Gly-Val- X -Ser-VaJ-Sar- X - X -GJy- 
-V&II-LetI-Gin- 
Se~-L~U-+hC-V~1-S~~-Leu-Bcr-Pyr-Tyr-p~O-~~~- 
-Aep-Gin-TRr-Ssr-Aen-lie-VoO-The-Ala-Scr- 
-V&B1 -lop-Leu-l,yS 
Aln-Asp-Oly-Val-AeP-Cly-Leu-Aln-Phc-PhQ-P~Q- 
-LcU-Ale-Ppo-Ala-Aan-Ser-OLn-lle-Pro-Ber- 
-GIY-SEr-$er-Ala-Gly-Met-Phe-Gly-I&U-Phc- 
-eye-scr-Scr- 
PRe-Am-His-Asp-lie-Leu-Ser-Trp-TYP-Phe- 
-ThP-Scr-Asn-Lcu-Glu-PPO-Aan-Alo- 
-V~l-A~~-Gl~-AlJl-Gi~ 
Ala-A8p-Cly-Va1-Anp-Gly-L.,U-Ala-Phe-Phe- 
-LEU-A~~-P~O-A~~-AB~-S~~-G~~-I~~-P~O-SCP- 
-GlP-See-Ser-Ala-Glu-Yo+-Phf-Clv-Lcu-Phc- 
Fig. 1. Reversed-phase HPLC of Lys-C digest of purified LAA-I on a column of CIIJ. The residues which were difficult to identify are written in 
italics. A minor peptide in a fragment is marked with an asterisk. 
=--T-T- 
tlmo, mln 
t’ig 2, Rcvcrssd-phase HPLC of Asp-N digest of purified LA&I on a column of C 14, ‘I-tic residues which were difficult to identify are written 
in irnlica. A minor pcptidc in a fragment is marked with an axtcrisk, 
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~u-Asn-r;lu-Leu-~~Ph~Asn-~~As~~~s~~~Val-~~-Asn-Gln-Asn-As~-Il~Leu-~:e-Gln-Gl~-VaI-Ala-Se~-Val-SerWlp 
q______l ;&.A18 -.I......- 
_ A4 - 
x .I.,...._ - L15-----_*..~.“.-------_ 
- A12 
^_ ..,.... I_.“......_ 
. . . . . . . . . P 33 ---------------Ll 
---Al7 _ ---------------Al 
A4-X- 
_ _~_~_ 
-,A 22 _.a ..,..a _ 
A10 - 
p X -Al3 p -A14 - 
----------------------A15 .I.....,,_ A12 - 
- A5----- 
--_.M.....-A 3 
AspPro-Aep-Ph~Lys-His-Ile-Gly-Val-~~~Val-Aen-Ser-Ile-L~s-SerIle-~a-~~~~~-Lys-Trp-lsp-7rpArg-bsn-Gly-Asp- 
I,.. . ..I. ----------_L3 
---------------L- 
I....... A10 -A2 
E------ 
A&-...,,.,. _I___.* . . . . . . . . . . . . . ..I_ Y-- 
A2 111..,.,1. ,.., . . . . 
Fig. 3. Complere amino-acid scquencc of LAA-I. Primary wucture in term5 of the peptides obroined afrcr diyesrion with Lys.C (L) and Asp-N 
(A). Residues wcrc idcnrified by automated sequence analysis of tlw LysC fragmcms (-.-L-w-) or of rhe Asp-N fragnients (-..A---). Dashes show 
reriducs not dekrmincd clearly ar this position. 
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sequences to obtain the complete amino-acid sequences 
of LAA-I, Fig. 3. The structure of this lectin contains 
250 amino-acid residues. The molecular weight of this 
lectin calculated on the basis of the sequence is 
27 150.83. The apparent molecular weight determined 
by SDS polyacrylamide gel electrophoresis described 
previously (32000) [6] is in good agreement with this 
finding. As shown in Fig. 4, complete sequence of this 
Laburnum alpinum lectin I was compared with those of 
Ulexeuropeus lectins I and II (UEA-I and II) [8], Lotus 
tetrugonolobus lectin (LTA) [7], Con A [lo], Glycine 
mux (soy bean) lectin (SBA) [I 11, Dolichos bifforus 
anti-A lectin (DBA) [ 121, Viciu fuba lectin (Favin) [ 131, 
Lens cuiinaris (lentil) lectin (LCL) [14], Pisum sativum 
lectin (pea) [15], Onobrychis vicifolia (sainfoin) lectin 
(SL) [16], fhuseolus vulgaris lectin (PHA) [17], 
Larhyrus ochrus lectin (LOL) [18], Erythrina cor- 
ullodendron lectin (ECorL) [ 191 and Phaseolus limensis 
lectin (LBL) [20]. Overall identity values between LAA- 
I and the other sequenced proteins, UEA-I and II, 
LTA, Con A, SBA, DBA, Favin, LCL, pea, SL, PHA, 
Fig. 5. Comparison of the hydropathy plots and predicted secondary structure analyses of LAA-I, UEA-I, UEA-II and Con A. The hydropathic 
scale is given on the left according to Kyte and Doolittle [9] with (- ) indicating relative hydrophilicity atid (+ ) indicating relative hydrophobicity. 
The P-sheet and a-helix scores are given on the left. The sequence of Con A is presented in a permlrted arrangement to maximize homology. 
a, hydropathy profiles; b, a-helix; c, &sheet. 
LOL, ECorL and LBL are 51.4%, 82.7%, 42.2%, 
39.9%, 48.2%, 45.4%, 40.0010, 34.8%, 41.0%, 37.6%, 
45.2%, 42.7% and 37.7010, respectively. Fig. 5 shows 
the hydropathy plots and predicted secondary struc- 
tures for LAA-I, UEA-I, UEA-II and Con A. The se- 
quences are presente& as linear hydropathy plots to il- 
lustrate the marked similarities in the distributions of 
hydrophilic and hydrophobic regions not evident from 
a comparison of their amino acid sequences. 
4. DISCUSSION 
The amino-acid seqrlence of the Laburnum alpinum 
lectin I (LAA-I) was compared with those of several lec- 
tins which have been determined so far, Fig. 4. This 
Laburnum lectin has a more striking homology wit!1 the 
[/lex europeus lectin 31 (UEA-II) than with any other 
lectins including the Ulex isolectin, UEA-I. According 
to our previous paper [8] overall positional identity be- 
tween UEA-I and 11 was 52.0%. On the other hand, 
overall identity between LAA-I and WA-11 is 82,7%. 
37 
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Since these two lectins are di-N-acetylchitobiose- 
binding lectins, this extreme homology is presumed to 
ba related to their sugar binding specificity. 
Despite the differences in the properties among these 
lectins, the comparison of their primary sequences in- 
dicates specific residues and structural domains that are 
highly conserved. Most noteworthy residues are those 
implicated in the metal binding activities of Con A. 
Residues Glum8, Asp-“, Asp- l9 and His-24 of Con A 
involved in manganase binding and Asp-” Asn-14 and 
Asp-l9 involved in calcium binding are all Conserved in 
this Laburnum lectin [21,22]. 
Residues Pre-68, SermT6, Phe-13’, Phe-l”, Pro-‘78, 
ValWt8’ and Ser-“’ which represent one-half of the 
residues of Con A involved in subunit-subunit interac- 
tions [23] are all but Phe-“’ conserved. This amino 
acid, Phe-‘75, is substituted by a homologous residue, 
Tyr. As for the residues related to the hydrophobic cavi- 
ty (Tyr -s4 LeuW81, LIZLI-~~, Vale8’, Phe-“‘, Val-‘79, 
Phe-19’ add PheW2”) all of the residues except Val-‘79 
are conserved in this lectin. Val-‘79 is exchanged by a 
homologous residue, lle. These extensive homologies 
demonstrate an evoktionary conservation. As for the 
residues of Con A involved in carbohydrate binding, 
only 4 residues (Tyr-I’, Asn-14, GIY-~~, AsP-“~), out 
of the 6 residues implicated in the carbohydrate binding 
of Con A [22], are conserved in LAA-I. 
The glycosylation sites were assumed to be at 
Asn-‘19. This is located in the unique sequence of -Tyr- 
Asn-Ser-Ser-. In the peptide fragments obtained after 
digestion of LAA-I with Asp-N, A15, and Al3 (as 
shown in Fig. 2) were found to have sequences Asp- 
Tyr-Asn-Ser-Ser-Asn-GIn-Ile-lle-Ala-Val-GIu-Phe- 
and Asp-Tyr-X-Ser-Ser-Asn-Gln-lle-lle-Ala-Val-Glu- 
Phe-, respectively. This fact suggests that LAA-I is 
partly glycosylated at position 119. Among the 
homologous lectins which contain carbohydrate, the 
glycosylation position is not always conserved, UEA-I 
is glycosylated at Asn-lo and Asn-‘16, UEA-II at 
Asn-‘!8 and Asnm2”, Favin at Asn-169, SBA at Asn-“, 
SL at Asn-*18, DBA at Asn-*14, and LTA at Asne4. 
As for the comparison of the hydropathy plots of 
LAA-I, UEA-II, UEA-I and Con A, Fig. 5, the most 
striking similarities occur between the region involving 
residues 100-230 of LAA-I and the region involving 
residues 220-110 of Con A, between residues 60-230 
of LAA-1 and residues 60-230 of UEA-II, and between 
38 
residues 140-220 of LAA-I and residues 140-220 of 
UEA-I. These notable similarities suggest that these lec- 
tins may have similar exposed and buried regions, sug- 
gesting similar polypeptide folding patterns. In addition 
to similarities in the hydropathicity profiles of these let- 
tins, secondary structure predictions of this Laburnum 
lectin and two Ulex lectins show an extensive network 
of P-sheet structures as in Con A [21]. 
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